Eli Lilly and Company
Developing medicines for needs
- B2B
- B2C
- Has physical offices
- Publicly traded
- Manufacturing
- Multi-product
- Sales-led purchase
About Eli Lilly and Company
A pharmaceutical company dedicated to discovering medicines, improving disease management, and giving back to communities through philanthropy and volunteerism
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- Indianapolis, Indiana, United States
- Revenue
- $65.2BFY2025, publicly reported
- Website
- lilly.com
Jobs at Eli Lilly and Company
- CDI - Technicien de Maintenance F/H
- Associate Director - Operations Process Lead
- Associate / Senior Associate /Manager CMC Regulatory Associate - GRA Regulatory Delivery Excellence
- Senior Director, Global Parenteral Drug Product Technical Services (MSAT)
- Associate Director - Radioligand Therapies Operations Lead
- Senior Director - Clinical Tech Design and Operations
- Director, Global Regulatory Affairs – CMC, Lifecycle Innovation
- Global Regulatory Lead - Immunology
Eli Lilly and Company in the news
- Katwijk approves permits for $3 billion Eli Lilly pharmaceutical plant
Eli Lilly's $3 billion pharmaceutical plant in Katwijk, Netherlands, received permit approval to manufacture diabetes and weight-loss medicines.
- Lilly bypasses Australian pharmacies with DTC model
Eli Lilly is adopting a direct-to-consumer sales model in Australia, while Novartis has acquired an experimental mRNA therapy from a Chinese firm, and NIH research grant funding is facing transparency issues.
- Foghorn lays off 40% of staff after Lilly collaboration ends
Foghorn Therapeutics cut 40% of its workforce and reprioritized its pipeline after Eli Lilly ended their oncology collaboration due to insufficient clinical efficacy of a key cancer drug candidate.
- Missed Out On The Eli Lilly & Novo Nordisk GLP-1 Boom? These 7 Stocks Could Benefit Next!
The document highlights several companies, including pharmaceutical firms and food manufacturers, that are poised to benefit from the ongoing GLP-1 drug boom.
- Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip
Eli Lilly's stock is recommended for purchase due to strong revenue growth from metabolic medicines, promising pipeline drugs, and strategic acquisitions despite competitive pricing pressures.
Eli Lilly and Company at a glance
Eli Lilly and Company is a B2B/B2C company in the Pharmaceutical Manufacturing industry, headquartered in Indianapolis, Indiana, United States.
Eli Lilly and Company has 10,000+ employees.
Eli Lilly and Company's revenue is $65.2B (FY2025, publicly reported).
Eli Lilly and Company is hiring: 8 recent open roles, including CDI - Technicien de Maintenance F/H, Associate Director - Operations Process Lead, Associate / Senior Associate /Manager CMC Regulatory Associate - GRA Regulatory Delivery Excellence.
Selling to companies like Eli Lilly and Company?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies